aspirin has been researched along with Hypertriglyceridemia in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although aspirin (ASA) remains the most popular and accepted agent for secondary stroke prevention, its efficacy does not exceed 25%." | 9.13 | Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke. ( Karepov, V; Kuliczkowski, W; Serebruany, V; Tolpina, G, 2008) |
| "Aspirin treatment lowers inflammation via inhibition of NF-κB activity but also reduces hypertriglyceridemia in humans." | 5.37 | Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. ( Berbée, JF; Havekes, LM; Rensen, PC; Romijn, JA; Shoelson, SE; van Diepen, JA; Voshol, PJ; Vroegrijk, IO, 2011) |
| "Although aspirin (ASA) remains the most popular and accepted agent for secondary stroke prevention, its efficacy does not exceed 25%." | 5.13 | Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke. ( Karepov, V; Kuliczkowski, W; Serebruany, V; Tolpina, G, 2008) |
| "7%), all at low dosage levels." | 1.35 | [Prescription patterns for antilipidemic drugs in a group of Colombian patients]. ( Machado, JE; Mesa, G; Moncada, JC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karepov, V | 1 |
| Tolpina, G | 1 |
| Kuliczkowski, W | 1 |
| Serebruany, V | 1 |
| van Diepen, JA | 1 |
| Vroegrijk, IO | 1 |
| Berbée, JF | 1 |
| Shoelson, SE | 1 |
| Romijn, JA | 1 |
| Havekes, LM | 1 |
| Rensen, PC | 1 |
| Voshol, PJ | 1 |
| Machado, JE | 1 |
| Moncada, JC | 1 |
| Mesa, G | 1 |
1 trial available for aspirin and Hypertriglyceridemia
| Article | Year |
|---|---|
Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Drug Resistance; Female; Humans; Hypertr | 2008 |
2 other studies available for aspirin and Hypertriglyceridemia
| Article | Year |
|---|---|
Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apolipoprotein C-I; Aspirin; Diet, High-Fat; Down- | 2011 |
[Prescription patterns for antilipidemic drugs in a group of Colombian patients].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antihypertensive Agents | 2008 |